BSP:DVAI34 (USA)  
DaVita Inc logo

DaVita Inc

R$ 427.42 (0%) Feb 3
P/E:
12.57
P/B:
14.52
Market Cap:
R$ 38.51B ($ 7.47B)
Enterprise V:
R$ 97.49B ($ 18.92B)
Volume:
-
Avg Vol (2M):
111.00
Also Trade In:
Volume:
-
Market Cap R$:
38.51B
Market Cap $:
7.47B
PE Ratio:
12.57
Avg Vol (2-Month):
111.00
Enterprise Value R$:
97.49B
Enterprise Value $:
18.92B
PB Ratio:
14.52

Business Description

Description
DaVita is the largest provider of dialysis services in the United States, boasting market share that eclipses 35% when measured by both patients and clinics. The firm operates over 3,100 facilities worldwide, mostly in the U.S., and treats over 240,000 patients globally each year. Government payers dominate U.S. dialysis reimbursement. DaVita receives approximately 69% of U.S. sales at government (primarily Medicare) reimbursement rates, with the remaining 31% coming from commercial insurers. However, while commercial insurers represented only about 10% of the U.S. patients treated, they represent nearly all of the profits generated by DaVita in the U.S. dialysis business.
Name Current Vs Industry Vs History
Cash-To-Debt 0.04
Equity-to-Asset 0.03
Debt-to-Equity 22.6
Debt-to-EBITDA 5.53
Interest Coverage 4.41
Piotroski F-Score 4/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score 1.4
Distress
Grey
Safe
Beneish M-Score -2.76
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC
Name Current Vs Industry Vs History
5-Day RSI 74.46
9-Day RSI 73.53
14-Day RSI 71.57
6-1 Month Momentum % -9.41
12-1 Month Momentum % -35.59

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 1.26
Quick Ratio 1.22
Cash Ratio 0.17
Days Inventory 4.87
Days Sales Outstanding 64.06
Days Payable 18.22

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio 16.4